We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.

NANOMEDICINES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2020 to 2027)

Nanomedicines Market, By Application (Cardiovascular, Anti-inflammatories, Anti-infectives, Neurology, Oncology, Others (dental, orthopedic, urology, ophthalmic)), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In: 17 Aug, 2020
Code: CMI393
Pages: 145
Formats: Excel and PDF
Industry: Pharmaceutical

Nanomedicine products have applications in drug delivery, in vivo imaging, in vitro diagnostics, regenerative medicine, dental, medical devices, and dermal applications. Major drivers for the global nanomedicine market constitutes of increasing government support as well as continuous increase in the occurrence of chronic diseases including diabetes, obesity, cancer, orthopedic diseases, and kidney disorder. Furthermore, major players in the global nanomedicine market are focused on R&D of new products to expand their product portfolio.

Key features of the study:

This report provides in-depth analysis of the Global Nanomedicines market and provides market size (US$ billion) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the Global Nanomedicines market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Abbott Laboratories, CombiMatrix Corporation, Clene Nanomedicine, Inc., Cellics Therapeutics, Inc., Nanobiotix S.A, Celgene Corporation, GE Healthcare, NanoViricides, Inc., Johnson & Johnson, Mallinckrodt plc., Sirnaomics Inc., Precision NanoSystems Inc., Merck & Company Inc., Nanosphere, Inc., Pfizer Inc., and Sigma-Tau Pharmaceuticals Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The Global Nanomedicines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Nanomedicines market

Detailed Segmentation:

Global Nanomedicines Market, By Application:

Cardiovascular
Anti-inflammatories
Anti-infectives
Neurology
Oncology
Others (dental, orthopedic, urology, ophthalmic)

Global Nanomedicines Market, By Region:

North America

By Application

Cardiovascular
Anti-inflammatories
Anti-infectives
Neurology
Oncology
Others (dental, orthopedic, urology, ophthalmic)

By Country

U.S.
Canada

Latin America

By Application

Cardiovascular
Anti-inflammatories
Anti-infectives
Neurology
Oncology
Others (dental, orthopedic, urology, ophthalmic)

By Country

Brazil
Mexico
Argentina
Rest of Latin America

Europe

By Application

Cardiovascular
Anti-inflammatories
Anti-infectives
Neurology
Oncology
Others (dental, orthopedic, urology, ophthalmic)

By Country

U.K.
Germany
France
Spain
Italy
Russia
Rest of Europe

Asia Pacific

By Application

Cardiovascular
Anti-inflammatories
Anti-infectives
Neurology
Oncology
Others (dental, orthopedic, urology, ophthalmic)

By Country

China
Japan
India
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East

By Application

Cardiovascular
Anti-inflammatories
Anti-infectives
Neurology
Oncology
Others (dental, orthopedic, urology, ophthalmic)

By Country

GCC Countries
Israel
Rest of Middle East

Africa

By Application

Cardiovascular
Anti-inflammatories
Anti-infectives
Neurology
Oncology
Others (dental, orthopedic, urology, ophthalmic)

By Country

North Africa
Central Africa
South Africa

Company Profiles

Abbott Laboratories *

Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies

CombiMatrix Corporation
Clene Nanomedicine, Inc.
Cellics Therapeutics Inc.
Nanobiotix S.A
Celgene Corporation
GE Healthcare
NanoViricides, Inc.
Johnson & Johnson
Mallinckrodt plc.
Sirnaomics Inc.
Precision NanoSystems Inc.
Merck & Company Inc.
Nanosphere, Inc.
Pfizer Inc.
Sigma-Tau Pharmaceuticals Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snippet, By Application
  - Market Snippet, By Country
  - Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Key Highlights
- Product launch
- PEST Analysis
- Technological Advancements
- Regulatory Scenario
- Mergers and Acquisitions
Global Nanomedicines Market, By Application, 2019 – 2027, (US$ Bn)
- Introduction
  - Market Share Analysis, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, 2017 – 2027
  - Segment Trends
- Cardiovascular
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Bn)
- Anti-inflammatories
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Bn)
- Anti-infective
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Bn)
- Neurology
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Bn)
- Oncology
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Bn)
- Others (dental, orthopedic, urology, opthalmic)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Bn)
Global Nanomedicines Market, By Region, 2019 – 2027, (US$ Bn)
- Introduction
  - Market Share Analysis, By Region, 2020 and 2027 (%)
  - Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
  - Market Size and Forecast, By Application, 2016 – 2027, (US$ Bn)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Bn)
    - U.S.
    - Canada
- Latin America
  - Market Size and Forecast, By Application, 2016 – 2027, (US$ Bn)Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Bn)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Bn)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Market Size and Forecast, By Application, 2016 – 2027, (US$ Bn)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Bn)
    - Germany
    - U.K.
    - France
    - Spain
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Market Size and Forecast, By Application, 2016 – 2027, (US$ Bn)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Bn)
    - China
    - Japan
    - India
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Market Size and Forecast, By Application, 2016 – 2027, (US$ Bn)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Market Size and Forecast, By Application, 2016 – 2027, (US$ Bn)
  - Market Size and Forecast, By Country, 2016 – 2027, (US$ Bn)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- Company Profiles
  - Abbott Laboratories
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - CombiMatrix Corporation
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Clene Nanomedicine, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Cellics Therapeutics Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Nanobiotix S.A
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Celgene Corporation
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - GE Healthcare
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - NanoViricides, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Johnson & Johnson
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Mallinckrodt plc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Sirnaomics Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Precision NanoSystems Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Merck & Company Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Nanosphere, Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Pfizer Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
  - Sigma-Tau Pharmaceuticals Inc.
    - Company Overview
    - Product Portfolio
    - Financial Overview
    - Key Highlights
    - Market Strategies
Section
- References
- Research Methodology
- About us and Sales Contact

*Browse 22 market data tables and 14 figures on “Nanomedicines Market - Global forecast to 2027”.

Limited Time Offer - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now